{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:42:08Z","timestamp":1781066528562,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00296-012-2399-z","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T14:44:58Z","timestamp":1332859498000},"page":"423-427","source":"Crossref","is-referenced-by-count":23,"title":["Effects of calcitonin on knee osteoarthritis and quality of life"],"prefix":"10.1007","volume":"33","author":[{"given":"Meltem","family":"Esenyel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afitap","family":"\u0130\u00e7a\u011fas\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem Zeki","family":"Esenyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,28]]},"reference":[{"issue":"8","key":"2399_CR1","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/art.22796","volume":"56","author":"SB Abramson","year":"2007","unstructured":"Abramson SB, Honig S (2007) Antiresorptive agents and osteoarthritis: more than a bone to pick? Arthritis Rheum 56(8):2469\u20132473","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2399_CR2","first-page":"222","volume":"65","author":"S Krasnokutsky","year":"2007","unstructured":"Krasnokutsky S, Samuels J, Abramson SB (2007) Osteoarthritis in 2007. Bull NYU Hosp Jt Dis 65(3):222\u2013228","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"2399_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/art.20051","volume":"50","author":"DT Felson","year":"2004","unstructured":"Felson DT, Neogi T (2004) Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum 50:341\u2013344","journal-title":"Arthritis Rheum"},{"key":"2399_CR4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.joca.2008.01.014","volume":"16","author":"MA Karsdal","year":"2008","unstructured":"Karsdal MA, Leeming DJ, Dam EB, Henriksen K, Alexandersen P, Pastoureau P et al (2008) Should subchondral bone turnover be targeted when treating osteoarthritis? Osteoarthr Cartil 16:638\u2013646","journal-title":"Osteoarthr Cartil"},{"key":"2399_CR5","first-page":"591","volume":"18","author":"MA Davis","year":"1991","unstructured":"Davis MA, Ettinger WH, Nuhaus JM (1991) Knee osteoarthritis and physical functioning: evidence from the NHANES 1 epidemiologic follow up study. J Rheumatol 18:591\u2013598","journal-title":"J Rheumatol"},{"key":"2399_CR6","first-page":"1037","volume":"23","author":"M Hopman-Rock","year":"1996","unstructured":"Hopman-Rock M, Oddind E, Hofman A (1996) Physical and psychological disability in elderly subjects in relation to pain in the hip and\/or knee. J Rheumatol 23:1037\u20131044","journal-title":"J Rheumatol"},{"key":"2399_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0049-0172(89)90016-4","volume":"18","author":"M Zimmermann","year":"1989","unstructured":"Zimmermann M (1989) Pain mechanisms and mediators in osteoarthritis. Semin Arthritis Rheum 18:51\u201356","journal-title":"Semin Arthritis Rheum"},{"key":"2399_CR8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/jcem-57-4-819","volume":"57","author":"TJ Chambers","year":"1983","unstructured":"Chambers TJ, Moore A (1983) The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. J Clin Endocrinol Metab 57:379\u2013385","journal-title":"J Clin Endocrinol Metab"},{"key":"2399_CR9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.joca.2006.03.014","volume":"14","author":"MA Karsdal","year":"2006","unstructured":"Karsdal MA, Tanko LB, Riis BJ, Sondergard BC et al (2006) Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA? Osteoarthr Cartil 14:617\u2013624","journal-title":"Osteoarthr Cartil"},{"key":"2399_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1196\/annals.1402.041","volume":"1117","author":"MA Karsdal","year":"2007","unstructured":"Karsdal MA, Sondergaard BC, Arnold M, Chistiansen C (2007) Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis? Ann NY Acad Sci 1117:181\u2013195","journal-title":"Ann NY Acad Sci"},{"key":"2399_CR11","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/art.22797","volume":"2007","author":"BC Sondergaard","year":"2007","unstructured":"Sondergaard BC, Ostergaard S, Christiansen C, Karsdal MA (2007) The effect of oral calcitonin on cartilage turn overhand surface erosion in the ovariectomized rat model. Arthritis Rheum 2007:2674\u20132678","journal-title":"Arthritis Rheum"},{"key":"2399_CR12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.joca.2004.08.005","volume":"12","author":"H El Hajjaji","year":"2004","unstructured":"El Hajjaji H, Williams JM, Devogelaer JP, Lenz ME, Thonar EJ, Manicourt DH (2004) Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis. Osteoarthr Cartil 12:904\u2013911","journal-title":"Osteoarthr Cartil"},{"key":"2399_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/art.1780330410","volume":"33","author":"MT Hannan","year":"1990","unstructured":"Hannan MT, Felson DT, Anderson JJ, Naimark A, Kannel WB (1990) Estrogen use and radiographic osteoarthritis of the knee in women: the Framingham Osteoarthritis Study. Arthritis Rheum 33:525\u2013532","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2399_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.joca.2004.10.010","volume":"13","author":"EH T\u00fcz\u00fcn","year":"2005","unstructured":"T\u00fcz\u00fcn EH, Eker L, Aytar A, Da\u015fkapan A, Bayramo\u011flu M (2005) Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthr Cartil 13(1):28\u201333","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"2399_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s10067-002-0653-6","volume":"22","author":"H Ko\u00e7yigit","year":"2003","unstructured":"Ko\u00e7yigit H, G\u00fclseren \u015e, Erol A, Hizli N, Memis A (2003) The reliability and validity of the Turkish version of quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO). Clin Rheumatol 22(1):18\u201323","journal-title":"Clin Rheumatol"},{"key":"2399_CR16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/ncprheum0193","volume":"2","author":"SB Abramson","year":"2006","unstructured":"Abramson SB, Attur M, Yazici Y (2006) Prospects for disease modification in osteoarthritis. Nat Clin Pract Rheumatol 2:304\u2013312","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2399_CR17","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1002\/art.22160","volume":"54","author":"CO Bingham","year":"2006","unstructured":"Bingham CO, Buckland-Wright JC, Garnera P et al (2006) Risedronate decreases biomechanical markers of cartilage degradation but does not decrease symptoms or slow X-ray progression in patients with medial compartment osteoarthritis of the knee: results of 2\u00a0year multinational knee OA structural arthritis (KOSTAR) study. Arthritis Rheum 54:3494\u20133507","journal-title":"Arthritis Rheum"},{"key":"2399_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2474-11-125","volume":"11","author":"MA Karsdal","year":"2010","unstructured":"Karsdal MA, Byrjalsen I, Bay-Jensen AC, Henriksen K, Riis BJ, Christiansen C (2010) Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis\u2014the effect of sex, Kellgren\u2013Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation. BMC Musculoskelet Disord 11:125","journal-title":"BMC Musculoskelet Disord"},{"key":"2399_CR19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2174\/092986730611220401164504","volume":"6","author":"PM Sexton","year":"1999","unstructured":"Sexton PM, Findlay DM, Martin TJ (1999) Calcitonin. Curr Med Chem 6:1067\u20131093","journal-title":"Curr Med Chem"},{"key":"2399_CR20","first-page":"285","volume":"5","author":"DH Manicourt","year":"2005","unstructured":"Manicourt DH, Devogelaer JP, Azria M, Silverman S (2005) Rationale for the potential use of calcitonin in osteoarthritis. J Muskuloskelet Neuronal Interact 5:285\u2013293","journal-title":"J Muskuloskelet Neuronal Interact"},{"key":"2399_CR21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF01899928","volume":"25","author":"TJ Martin","year":"1969","unstructured":"Martin TJ, Haris GS, Melick RA, Fraser JR (1969) Effect of calcitonin on glycosaminoglycan synthesis by embryo calf bone cells in vitro. Experientia 25:375\u2013376","journal-title":"Experientia"},{"key":"2399_CR22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5694\/j.1326-5377.1968.tb28459.x","volume":"1","author":"E Baxter","year":"1968","unstructured":"Baxter E, Fraser JR, Harris GS, Martin TJ, Melick RA (1968) Stimulation of glycosaminoglycan synthesis by thyrocalcitonin preparations. Med J Aust 1:216\u2013217","journal-title":"Med J Aust"},{"key":"2399_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/jcem-69-2-259","volume":"69","author":"P Franchimont","year":"1989","unstructured":"Franchimont P, Basleer C, Henrotin Y, Gysen P, Basleer R (1989) Effects of human and salmon calcitonin on human articular chondrocytes cultivated in clusters. J Clin Endocrinol Metab 69:259\u2013266","journal-title":"J Clin Endocrinol Metab"},{"key":"2399_CR24","volume-title":"The calcitonins (physiology and pharmacology)","author":"M Azria","year":"1989","unstructured":"Azria M (1989) The calcitonins (physiology and pharmacology). Karger, Basel"},{"key":"2399_CR25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S8756-3282(02)00714-7","volume":"30","author":"GP Lyritis","year":"2002","unstructured":"Lyritis GP, Trovas G (2002) Analgesic effects of calcitonin. Bone 30:715\u2013745","journal-title":"Bone"},{"key":"2399_CR26","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00002512-199608050-00006","volume":"8","author":"GL Plosker","year":"1996","unstructured":"Plosker GL, McTavish D (1996) Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis. Drugs Aging 8:378\u2013400","journal-title":"Drugs Aging"},{"issue":"Suppl A","key":"2399_CR27","first-page":"142","volume":"13","author":"BS Sondergaard","year":"2005","unstructured":"Sondergaard BS, Olsen AK, Sumer EU, Quvist P, Bagger YZ, Tanko LB et al (2005) Calcitonin stimulates proteoglycan and collagen type I1 biosynthesis in articular cartilage ex vivo. Osteoarthr Cartil 13(Suppl A):142","journal-title":"Osteoarthr Cartil"},{"issue":"8","key":"2399_CR28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.joca.2006.01.014","volume":"14","author":"BC Sondergaard","year":"2006","unstructured":"Sondergaard BC, Wulf H, Henrikksen K, Schaller S, Oestergaard S, Qvist P et al (2006) Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression. Osteoarthr Cartil 14(8):759\u2013768","journal-title":"Osteoarthr Cartil"},{"key":"2399_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1063-4584(97)80005-2","volume":"5","author":"MP Helio","year":"1997","unstructured":"Helio MP, Peschard MJ, Cohen C, Richard M, Vignon E (1997) Calcitonin inhibits phospholipase A2 and collagenase activity of human osteoarthritic chondrocytes. Osteoarthr Cartil 5:121\u2013128","journal-title":"Osteoarthr Cartil"},{"key":"2399_CR30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/ar1152","volume":"6","author":"P Hoegh-Andersen","year":"2004","unstructured":"Hoegh-Andersen P, Tanko LB, Andersen TL, Lundberg CV, Mo JA, Heegaard AM et al (2004) Ovariectomized rats as model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther 6:169\u2013180","journal-title":"Arthritis Res Ther"},{"key":"2399_CR31","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1359\/JBMR.040715","volume":"19","author":"LB Tanko","year":"2004","unstructured":"Tanko LB, Bagger YZ, Alexandersen P, Devogelaer JP, Reginster JY, Chick R et al (2004) Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover. J Bone Miner Res 19:1531\u20131538","journal-title":"J Bone Miner Res"},{"key":"2399_CR32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bone.2005.04.032","volume":"37","author":"YZ Bagger","year":"2005","unstructured":"Bagger YZ, Tanko LB, Alexandersen P, Karsdal MA, Olson M, Mindeholm L et al (2005) Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone 37:425\u2013430","journal-title":"Bone"},{"issue":"10","key":"2399_CR33","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/art.22075","volume":"54","author":"DH Manicourt","year":"2006","unstructured":"Manicourt DH, Azria M, Mindeholm L, Thonar EJ, Devogelaer JP (2006) Oral salmon calcitonin reduces Lequesne\u2019s algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum 54(10):3205\u20133211","journal-title":"Arthritis Rheum"},{"key":"2399_CR34","first-page":"88","volume":"13","author":"DH Manicourt","year":"2005","unstructured":"Manicourt DH, Azria M, Mindeholm L, Devogelaer JP (2005) Efficacy of calcitonin therapy in patients with knee osteoarthritis: a clinical and biochemical preliminary study. Osteoarthr Cartil 13:88","journal-title":"Osteoarthr Cartil"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2399-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2399-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2399-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T13:47:16Z","timestamp":1687355236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2399-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,28]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2399"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2399-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,28]]}}}